PRTA
Prothena FY25 Earnings Review: Partnered Programs Advance Toward Milestones as Wholly-Owned Assets Pivot
Business Overview Prothena Corporation plc operates as a late-stage clinical biotechnology company focusing predominantly on the science of protein dysregulation.…
Prothena Corporation PLC (PRTA) Q4 2021 earnings call
Prothena Corporation PLC (NASDAQ: PRTA) Q4 2021 Earnings Conference